← Leaderboards
Hae J Park
University Of Colorado Denver
$153,008
Attributed
$153,008
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.8K · FY2019–22$100K$75K$50K$25K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$153,008 · 1
By mechanism
F30$153,008 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Angelo D'alessandro$12,761,823
- James V Degregori$21,700,379
- Christopher C Porter$2,117,025
- Carla Parry$685,005
- Douglas K Graham$6,579,169
Others in their field
Other Emerging Leaders on “Gene Expression”
- Evan Z Macosko · Broad Institute, Inc.$35,121,158
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$26,358,801
- Benjamin E Deverman · Broad Institute, Inc.$16,920,984
- Tomasz Nowakowski · University Of California, San Francisco$15,628,426
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Crystal Mackall · Children'S Hosp Of Philadelphia$14,040,300
Research focus
Gene ExpressionGenesAcute LeukemiaAcute Myelocytic LeukemiaAcute Myeloid Leukemia CellAntioxidantsApoptosisAdultAtaxia Telangiectasia Mutated ProteinAdult LeukemiaAkt Signaling PathwayBone MarrowCell DeathCellsChildhood LeukemiaCombinatorialApoptoticCytoprotectionCytotoxicDisease RemissionDrug ResistanceDrug TargetingExperimental StudyGenetic
Grant awards (4)
Understanding the mechanism of bone marrow stromal cell-mediated protection of FLT3-ITD AML from FLT3-targeted therapy$51,752
F30 · FY2022 · CA · contact PI
Understanding the mechanism of bone marrow stromal cell-mediated protection of FLT3-ITD AML from FLT3-targeted therapy$34,264
F30 · FY2021 · CA · contact PI
Understanding the mechanism of bone marrow stromal cell-mediated protection of FLT3-ITD AML from FLT3-targeted therapy$33,748
F30 · FY2020 · CA · contact PI
Understanding the mechanism of bone marrow stromal cell-mediated protection of FLT3-ITD AML from FLT3-targeted therapy$33,244
F30 · FY2019 · CA · contact PI